Iterum Therapeutics PLC (ITRM)vsRevolution Medicines Inc (RVMD)
ITRM
Iterum Therapeutics PLC
$0.03
0.00%
HEALTHCARE · Cap: $1.60M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Revolution Medicines Inc generates 90% more annual revenue ($742,000 vs $390,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. ITRM earns a higher WallStSmart Score of 25/100 (F).
ITRM
Avoid25
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : ITRM
The strongest argument for ITRM centers on Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ITRM
The primary concerns for ITRM are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
ITRM carries more volatility with a beta of 3.01 — expect wider price swings.
RVMD is growing revenue faster at -95.2% — sustainability is the question.
ITRM generates stronger free cash flow (-8M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ITRM scores higher overall (25/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Iterum Therapeutics PLC
HEALTHCARE · BIOTECHNOLOGY · USA
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, is engaged in the development of anti-infectives for multidrug resistant pathogens in Ireland and the United States. The company is headquartered in Dublin, Ireland.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?